Humana Inc. reported its financial results for the second quarter of 2025, showcasing significant performance metrics and updates. The company announced earnings per share $(EPS)$ of $4.51 on a GAAP basis, with an adjusted EPS of $6.27 for the quarter. Year-to-date EPS stood at $14.81 on a GAAP basis and $17.85 on an adjusted basis. The insurance segment benefit ratio was reported at 89.9%, aligning with the company's previous expectation of approximately 90%. Humana revised its full-year 2025 GAAP EPS guidance to approximately $13.77, down from the prior estimate of approximately $14.68. However, it raised its adjusted FY 2025 EPS guidance to approximately $17.00, from the previous guidance of approximately $16.25. In terms of revenue, Humana increased its full-year 2025 consolidated revenue guidance to at least $128 billion, up from the previous range of $126 billion to $128 billion. The company also affirmed its FY 2025 insurance segment benefit ratio guidance range of 90.1% to 90.5%. Humana highlighted the strategic focus on investing in improved outcomes, operational excellence, and enhancing customer and investor experiences.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。